
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Irritable Bowel Syndrome With Constipation (IBS-C)
View Full LandscapeTarget Indication
Irritable Bowel Syndrome With Constipation (IBS-C)
Clinical Trial
NCT02493036Last updated: 1/2/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Pancreas Cancer, Metastatic
Healthy Volunteers
Healthy Volunteers With Ileostomy
Irritable Bowel Syndrome With Constipation (IBS-C)
Pancreatic Adenocarcinoma